In The Press
Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania
Ovation Science Inc. launches its patented cannabis products in Pennsylvania through PA Options for Wellness, offering advanced transdermal and topical solutions powered by Invisicare® technology. With over 850,000 registered medical cannabis patients, this collaboration enhances patient care with research-backed, highly effective cannabinoid delivery systems.
Ovation Science Topicals Launch with Planet 13 in Nevada
Ovation Science announced the official launch of Ovation's topical product line in Nevada. These products, powered by Ovation's patented skin delivery technology, will be available in-store at Planet 13's SuperStore and online. The partnership aims to expand Planet 13's product offerings and leverage its production facility to manufacture the cannabis-derived topicals.
Ovation Science Expands Market Reach with Exclusive Canadian License Agreement
Ovation Science announced the signing of an exclusive licensing agreement for Ovation’s products for Canada with Ripco Processing Inc. a company based in Calgary, Alberta and founded by successful legal cannabis pioneers.
Latest Podcast: Topical Delivery of Cannabinoids
Explore the cutting-edge world of Ovation Science with CEO Terry Howlett and Anil Mall, as they discuss the company's innovative CBD/THC skincare products and patented Invisicare® technology in this episode.
Ovation’s President Terry Howlett Answers Questions on The Watchlist
Ovation’s President Terry Howlett recently appeared on The Watchlist to discuss the company’s latest License Agreement for its topical/transdermal cannabis products in Missouri.
Ovation Science Announces License Agreement for Its Topical / Transdermal Cannabis Products for Missouri
Ovation Science announced the signing of an exclusive licensing agreement for Ovation’s topical / transdermal formulations for the state of Missouri.
Ovation Science Inc. Announces Changes
Ovation Science is pleased to announce the appointment of Shane Dungey and Ronald Stern to the Board of Directors.
Ovation Science Inc. Closes Private Placement
Ovation Science announces that there was an error in its news release dated October 12, 2023. The Company issued 4,000,000 Units at a price of $0.05 per unit for gross proceeds of $200,000.
Ovation Science Inc. Announces Private Placement
Ovation Science announces a proposed private placement offering of up to 4,000,000 units (each a “Unit”) at a price of $0.05 per Unit for total proceeds of up to $200,000 (the “Offering”).
Ovation Science Signs License Agreement with Planet 13 for Its Topical / Transdermal Cannabis Products for Nevada
Ovation Science with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare® announced the signing of an exclusive licensing agreement with Planet 13 Holdings, Inc.